We are live on ! Find out more
FCSC

Fibrocell Science Inc.
FCSC

Delisted

FCSC was delisted on the 12th of December, 2019.

Back to rankings

32 hedge funds and large institutions have $8.08M invested in Fibrocell Science Inc. in 2017 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 4

14% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 7

0% more funds holding

Funds holding: 32 → 32 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

67% less capital invested

Capital invested by funds: $24.2M → $8.08M (-$16.1M)

Holders
32
Holders Change
–
Holders Change %
0%
% of All Funds
0.73%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
8
Reduced
4
Closed
7
Calls
$30K
Puts
–
Net Calls
+$30K
Net Calls Change
-$9K

Top Buyers

Rank Fund Capital Flow
1
TS
Third Security
Virginia
+$4.77M
2
SM
Sabby Management
Florida
+$1.97M
3
AC
Armistice Capital
New York
+$1.07M
4
AFM
Anson Funds Management
Texas
+$783K
5
FPF
FNY Partners Fund
New York
+$350K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.8M
2
PPA
Parametric Portfolio Associates
Washington
-$148K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$107K
4
ARTA
A.R.T. Advisors
New York
-$52K
5
CCA
Conservest Capital Advisors
Pennsylvania
-$51K
Name Holding Trade Value Shares
Change 		Change in
Stake
TS
1
Third Security
Virginia
$5.29M +$4.77M +545,455 +49%
SM
2
Sabby Management
Florida
$733K +$1.97M +225,718 New
MP
3
MSD Partners
New York
$443K – – –
AC
4
Armistice Capital
New York
$393K +$1.07M +122,779 New
AFM
5
Anson Funds Management
Texas
$287K +$783K +89,627 New
Vanguard Group
6
Vanguard Group
Pennsylvania
$174K -$107K -12,259 -19%
FPF
7
FNY Partners Fund
New York
$129K +$350K +40,000 New
Point72 Asset Management
8
Point72 Asset Management
Connecticut
$128K +$350K +40,000 New
Renaissance Technologies
9
Renaissance Technologies
New York
$82K +$17.5K +2,006 +8%
Cambridge Investment Research Advisors
10
Cambridge Investment Research Advisors
Iowa
$60K +$44.2K +5,058 +37%
Creative Planning
11
Creative Planning
Kansas
$60K +$55.9K +6,400 +52%
VF
12
Virtu Financial
New York
$58K +$96.4K +11,033 +152%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$38K – – –
Morgan Stanley
14
Morgan Stanley
New York
$36K -$49.4K -5,646 -33%
Deutsche Bank
15
Deutsche Bank
Germany
$34K +$93.7K +10,718 New
BlackRock
16
BlackRock
New York
$28K – – –
California Public Employees Retirement System
17
California Public Employees Retirement System
California
$24K – – –
Bank of New York Mellon
18
Bank of New York Mellon
New York
$21K -$7.87K -900 -12%
SCA
19
STALEY CAPITAL ADVISERS
Pennsylvania
$19K – – –
UBS Group
20
UBS Group
Switzerland
$14K +$39.5K +4,520 +64,571%
FSA
21
Franklin Street Advisors
North Carolina
$11K – – –
Northern Trust
22
Northern Trust
Illinois
$10K – – –
Wells Fargo
23
Wells Fargo
California
$2K +$2.92K +334 +86%
Group One Trading
24
Group One Trading
Illinois
$2K +$5.48K +627 New
TWA
25
TCI Wealth Advisors
Arizona
$1K +$1.75K +200 +250%
1
2

FCSC Hedge Fund Activity: Q4 2017 in Review

32 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Fibrocell Science Inc. (FCSC) for Q4 2017, worth a combined $8.08M — down 67% from $24.2M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new FCSC positions and 7 closed out — a net gain of 1 holder — while 8 added to existing stakes and 4 trimmed.

The largest buyer was Third Security, adding an estimated $4.77M. The largest seller was Fidelity Investments, exiting entirely with an estimated $1.8M sold.

  • 32 institutional investors held Fibrocell Science Inc. (FCSC) as of Q4 2017, unchanged from Q3 2017.
  • Funds reported $8.08M of Fibrocell Science Inc. stock for Q4 2017, down 67% quarter-over-quarter.
  • 8 funds opened new Fibrocell Science Inc. positions in Q4 2017 and 7 closed out, a net change of +1 holder.
  • The largest Fibrocell Science Inc. buyer in Q4 2017 was Third Security, an estimated $4.77M added.
  • The largest Fibrocell Science Inc. seller in Q4 2017 was Fidelity Investments, an estimated $1.8M sold.

Based on aggregated 13F filings for Q4 2017.